亚博手机app

收藏我们
公告:
当前位置:亚博app下载 > 亚博手机app >
目录即将公布!这些药,有望进国家医保
作者:中糖院 时间:2020-11-15 12:20:52 浏览:141

  yiyaowang11yue11rixun jinru11yuehou,yiweizhe2020nianguojiayibaoyaopinmuludiaozhengjinrutanpanhejingjiajieduan,anzhaojihua,11-12yuejianggongbuzuizhongdeyibaodiaozhengmulu。

 

  医保目录种子选手,竞争格局如何?

 

亚博手机app  ciqianguojiayibaojugongshi《2020nianguojiayibaoyaopinmuludiaozhengtongguoxingshishenchadeshenbaoyaopinmingdan》,gongyou728geyaopintongguolexingshishencha;ciwai,muluneixuyaozhongxindiaozhengyibaozhifubiaozhun、shiyingzhengfashengzhongdagaibiandetanpanyaopin23geyekeyishenbao,jigongyou751gepinzhongtongguoxingshishencha。

 

亚博手机app  zaizheixiepinzhongzhong,genjushichangjingzhenggeju,naxiepinzhonggengyoukenengjinruyibao?

 

  据东莞证券分析师魏红梅梳理,按照《2020年国家医保药品目录调整工作方案》提出的可以纳入2020年药品目录拟新增药品范围的七大条件,在纳入《新型冠状病毒肺炎诊疗方案(试行第七版)》的药品这一条件中,共有12个品种通过形式审查,11个西药,1个中药,包含5个抗病毒、6个消化道及代谢和1个消食类药品。根据样本医院亚博手机app销售来看,酪酸梭菌活菌片、酪酸梭菌活菌散和酪酸梭菌二联活菌散2019年样本医院销售收入靠前,分别为6405万元、4466万元和3038万元。在竞争格局中,利巴韦林的竞争最为激烈,共有44家企业生产。

 

亚博手机app  qizhong,laosuansuojunerlian、ningjieyabaoganjunhuojunpian、yansuanabiduoerkeli、junqichangweihejiweidujiapinzhong,

 

亚博手机app  zainaru《guojiajibenyaowumulu(2018nianban)》deyaopinzhong,gongyou11gepinzhongtongguoxingshishencha,xiyao8ge,zhongyao3ge。fuhelinsuanqingjiazhusheyeshiqizhongdepinzhong,gong8jiashengchanchangshang,2019nianyangbenyiyuanxiaoshoushouru9574.06wanyuan。chucizhiwai,zhusheyongduozhongweishengsu(12)heyansuanxiaoxuanshanlangdangjianzhusheyejinsuiqihou,xiaoshouejin5000wanyuan,danhouzheyinweishengchanchangjiajiaoduo,jingzhengjilie。erniuhuangqingganjiaonanghetangcaopianweidujiapinzhong。

 

  yibaojudediaozhengguizeyidingchengdushangyinhanzhe“yaowujingjixuechengweizhuyaobiaozhun”zheiyitiaojian,jingzhenggejuzezhijieyingxiangzhexiangguanbumenduipinzhongdekaoliang。

 

  erdujiapinzhongzuoweiqiyedehexinpinzhong,shifoujinruyibaodeyingxiangshenyuan。cengyouzhuanjiagaosusaibolan:duidujiapinzhonglaishuo,ruguoyouleisichanpinzaiyibaochangguimuluzhong,jinjinshijixingbutong,jiyoukenengnaruchangguimulu,zhunruyibao;ruguomeiyouleisichanpin,zuoweidujiachanpinjinxingyibaotanpan,keyixiangshouyibaotanpanluodihongli,biruzhijieguawang,difangbudejinxingerciyijia,keyijishijinyuanhuijihuanzhe。

 

  哪些药,较大可能进医保?

 

  据了解,医保局的调整规则重点考虑临床必需、集中采购、创新药和地方用药,这也能从?海选目录?的品种分析中看到。

 

  比如第二批国家组织药品集中采购中选药品中,紫杉醇白蛋白、安立生坦、他达拉非为金医保,但因为以量换价,价格大幅下降,减轻医保压力,无需占用太多医保基金,这三个品种有较大可能进入医保。

 

亚博手机app  dongguanzhengquanyanbaoxianshi,gongyou28gepinzhong,fuhenaru《linchuangjixujingwaixinyaomingdan(diyipi)》《linchuangjixujingwaixinyaomingdan(dierpi)》《diyipigulifangzhiyaopinmulu》《shoupiguliyanfashenbaoertongyaopinqingdan》huo《disanpiguliyanfashenbaoertongyaopinqingdan》,bingzai2020nian8yue17riqianpizhunshangshidetiaojian。

 

  zaizhei28gepinzhongzhong,chugouyuansuanxidineifeipian、zuoyilaxitanzhusheyongnongrongyehequqianlienierzhusheyewai,qiyujunweidujiapinzhong——zheiyiweizheyou25geshidujialinchuangbixuchanpin,fuheyibaodiaozhengguize?linchuangbixu?deyaoqiu。

 

  据医药经济报梳理,进入条件三的单抗类产品都进入了条件五,符合条件五的单抗类品种就有24个,其中,强生的3个产品以条件三进入医保调整目录中,分别是阿帕他胺片、古塞奇尤单抗注射液和乌司奴单抗注射液。

 

目录即将公布!这些药,有望进国家医保

  

(tupianlaiyuan:yiyaojingjibao)

 

  ciwai,gongyoubaokuo154gexiyaohe17gezhongyaozaineide171gepinzhongtongguoxingshishencha,weiguidingqijianjingguojiayaojianjupizhunshangshidexintongyongmingyaopin。zhiliaolingyuzhuyaofenbuzaikangaiyao、yinxiebing、mazui、aizibing、binggan、dianxian、xinxueguanyijiyixiehanjianbingdeng。

 

亚博手机app  zhidezhuyideshi,suoyouweijinruyibaodepd-1juntongguolexingshishencha。zaiquniangongbude2019guojiayibaomuluzhong,5jiayishangshidepd-1,2jiajinkou(kyao,oyao),2jiaguochan(junshishengwudeteruipulidankang,hengruizhiyaodekaruilizhudankang)junweijinruyibao,weiduhezidepd-1,xinda-lilailianhekaifadexindilidankangjinruleguojiayibaomulu。